Is there a difference in efficacy between steroid-sparing agents like methotrexate, mycophenolate, and azathioprine in the treatment of immune-mediated myopathies?
Answer from: at Academic Institution
Currently, there is no high-quality evidence favoring one immunosuppressive agent over another in the treatment of immune-mediated myopathies, as there are no head-to-head comparative trials and most available data come from small, observational, or retrospective studies. As a result, the choice of ...
Comments
at Austin Regional Clinic @Eleni Tiniakou Thank you for your insightful answ...
at U.S. Department of Veterans Affairs I tend to choose MTX for inflammatory arthritis, M...
at The University of Texas Health Science Center at Houston (UTHealth) @Matthew Dwyer It depends on several factors, incl...
@Eleni Tiniakou Thank you for your insightful answ...
I tend to choose MTX for inflammatory arthritis, M...
@Matthew Dwyer It depends on several factors, incl...